IL21 and Autoimmunity: Collectively, these findings raise the possibility that the exacerbated IL-21 production that has been widely reported across many autoimmune conditions (85–91) may contribute to disease development by allowing selection, expansion and differentiation of GC B-cell clones that would otherwise be outcompeted (Fig. 2).